BACKGROUND: Depressive symptoms are highly prevalent among patients with multiple sclerosis (MS). Web-based problem solving therapy (PST) is easily accessible and showed to be effective in depressed patients. OBJECTIVES: The aims of this pilot study were to examine feasibility and outcome (reduction of depressive symptoms) of an applied web-based PST intervention in MS patients. METHODS: Forty-four MS patients with mild to severe depressive symptoms followed a web-based PST intervention. Feasibility was measured by compliance rate and satisfaction scales. The Beck Depression Inventory (BDI-II) was used to measure depressive symptoms before and after the intervention. RESULTS: The compliance rate was 52%, and 85% of the patients rated the quality of the intervention as good or excellent. After the intervention, depressive symptoms had significantly decreased (BDI-II change: mean=-3.9, p=0.01, d=0.51 in intention-to-treat analysis; BDI-II change: mean=-9.0, p<0.001, d=1.50 in completers analysis). CONCLUSIONS: This study suggests that applied web-based PST is feasible and reduces depressive symptoms in MS patients. Especially MS patients who experience disease-related or other barriers to participate in face-to-face counselling could benefit. However, ways to increase compliance should be considered. A randomized controlled trial is recommended to more extensively investigate effectiveness of this intervention in treating depressive symptoms in MS patients.
BACKGROUND:Depressive symptoms are highly prevalent among patients with multiple sclerosis (MS). Web-based problem solving therapy (PST) is easily accessible and showed to be effective in depressedpatients. OBJECTIVES: The aims of this pilot study were to examine feasibility and outcome (reduction of depressive symptoms) of an applied web-based PST intervention in MSpatients. METHODS: Forty-four MSpatients with mild to severe depressive symptoms followed a web-based PST intervention. Feasibility was measured by compliance rate and satisfaction scales. The Beck Depression Inventory (BDI-II) was used to measure depressive symptoms before and after the intervention. RESULTS: The compliance rate was 52%, and 85% of the patients rated the quality of the intervention as good or excellent. After the intervention, depressive symptoms had significantly decreased (BDI-II change: mean=-3.9, p=0.01, d=0.51 in intention-to-treat analysis; BDI-II change: mean=-9.0, p<0.001, d=1.50 in completers analysis). CONCLUSIONS: This study suggests that applied web-based PST is feasible and reduces depressive symptoms in MSpatients. Especially MSpatients who experience disease-related or other barriers to participate in face-to-face counselling could benefit. However, ways to increase compliance should be considered. A randomized controlled trial is recommended to more extensively investigate effectiveness of this intervention in treating depressive symptoms in MSpatients.
Authors: Hanna M Heller; Annemieke van Straten; Christianne J M de Groot; Adriaan Honig Journal: BMC Pregnancy Childbirth Date: 2014-08-14 Impact factor: 3.007
Authors: Rosa E Boeschoten; Joost Dekker; Bernard M J Uitdehaag; Chris H Polman; Emma H Collette; Pim Cuijpers; Aartjan T F Beekman; Patricia van Oppen Journal: BMC Psychiatry Date: 2012-09-11 Impact factor: 3.630
Authors: Johanna Freund; Ingrid Titzler; Janika Thielecke; Lina Braun; Harald Baumeister; Matthias Berking; David Daniel Ebert Journal: BMC Psychiatry Date: 2020-08-27 Impact factor: 3.630